Vimarsana
Biggest News Aggregation in the World

Page 4 - Cellular Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Therapy Today - Breaking & Trending Today

Rising Cases of Undiagnosed Immune Deficiency in Indian Children - Vimarsana News

Rising Cases of Undiagnosed Immune Deficiency in Indian Children

Rising cases of undiagnosed immune deficiency in Indian children underscore urgent need for awareness and early diagnosis.

Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma - Vimarsana News

Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma

European Orphan Drug Designation qualifies NXC-201 for: 10 years of market exclusivity once authorized in the EUAccess to the EU centralized authorization procedureReduced fees for: EU protocol...

Early Responses With CTX130 Renew Hope for Anti-CD70 CAR T-Cell Therapy in Advanced RCC - Vimarsana News

Early Responses With CTX130 Renew Hope for Anti-CD70 CAR T-Cell Therapy in Advanced RCC

Samer A. Srour, MB ChB, MS, explains the significance of early safety and efficacy data with CTX130 in CD70-expressing clear cell renal cell carcinoma.

Undiagnosed immune deficiency rising among Indian children: Doctors - Vimarsana News

Undiagnosed immune deficiency rising among Indian children: Doctors

Undiagnosed immune deficiency is significantly rising among children under the age of five in India, said doctors here on Sunday, as part of the World Primary Immunodeficiency Week.Every year, April 22 to 29 is observed as World Primary ...

Study finds rise in volumes and survival after hematopoietic cell transplants among racial/ethnic minorities - Vimarsana News

Study finds rise in volumes and survival after hematopoietic cell transplants among racial/ethnic minorities

The volume of hematopoietic cell transplants rose among all racial/ethnic groups, but grew faster among African Americans and Hispanics compared with Non-Hispanic white individuals, mirroring changes in population growth rates.